Loading…
← CockpitCompetitor Analysis › TCMD Tactile Systems Technology, Inc.Open in the cockpit ↗

Tactile Systems Technology, Inc.TCMDCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical Specialties
Momentum leader 81
Mkt cap
$592M
US dollars, full cap
Free float
97%
of shares outstanding
$/day
$6.08M
20-day average traded
Fwd P/E
21.1×
forward earnings
ROIC−WACC
+6.0 pp
WACC 9.7%
Hurdle
-4 pp
Req g minus delivered
Next earnings
97 days
23 Feb 2027
Close · USD$26.42
1D+1.4%
1W-2.6%
1M+12.3%
3M+12.8%
6M+6.4%
YTD-8.9%
1Y+12.7%
ATR %4.0%
Beta1.14
52w lowhigh30.1% off high

What Tactile Systems Technology does

Employees: 1,086

Tactile Systems Technology at a glance

Size Tactile Systems Technology (TCMD) is a United States Health Care company (Medical Specialties) with a market value of $592M, the 2558th largest of 3,085 United States companies the cockpit tracks. Shares closed at $26.42 on 18 Nov 2026.

Performance Over six months the shares gained 6.4%, against -20.3% for the median peer and -2.2% for the United States market (cap-weighted) — 7th highest of 19 in its peer set.

Growth Revenue grew 14.4% over the last twelve months (peer median +6.5%); the operating margin is 9.5% (peer median 7.4%).

Valuation It trades at 21.1× forward earnings against a peer median of 23.5× (6th cheapest of 12).

Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is -4 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 6.0 points above its cost of capital (9.7% WACC).

Short interest Short interest is 12.4% of the free float (30 Oct 2026).

Next results Next results expected around 23 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026TCMD 103Peer median 81
Six months, rebased to 100: Tactile Systems Technology against the median of its 20 peers (local-currency closes).

Tactile Systems Technology financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$356M$330M$293M$274M$247M
Revenue growth—+12%+7%+11%—
Gross profit$272M$248M$214M$193M$172M
EBITDA$40.6M$35.9M$29.0M$22.1M$4.17M
Net income$23.8M$19.1M$17.0M$28.5M-$17.9M
Free cash flow$29.0M$40.4M$38.3M$33.4M$3.39M
Capital expenditure$3.33M$2.54M$2.51M$2.48M$1.92M
Total debt$17.1M$16.0M$45.1M$50.4M$72.2M

Quarterly statements and history in the cockpit →

Tactile Systems Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%0%+50%688581300314OBIOSGHTMEDINAN300952XVIVOPACB3012356031224728300869QDELZJYLTCMD6-month return →1-month return →
Up and to the right = strong over both horizons. Tactile Systems Technology is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%50×100×688581300314MEDINAN300952XVIVO6882363012351789605369QDELTCMDRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Tactile Systems Technology is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%-20%0%20%688581MEDINANXVIVO68823647283008691789605369TCMDGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Tactile Systems Technology is the large dot.

Tactile Systems Technology competitors and peer comparison

How Tactile Systems Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Tactile Systems Technology against its 20 peers (data as of 18 Nov 2026)
MeasureTCMDPeer medianRank in peer set
1-month return+12.3%-3.5%4th highest of 19
6-month return+6.4%-20.3%7th highest of 19
Distance from 52-week high-30.1%-35.0%8th highest of 20
Revenue growth (TTM)+14.4%+6.5%10th highest of 20
Operating margin9.5%7.4%8th highest of 20
Forward P/E21.1×23.5×6th cheapest of 12
Growth the price implies (Req g, 7 yrs)8.4%0.4%5th most demanding of 10
Growth delivered (Del g)+12.0%+6.7%5th highest of 10
Hurdle (Req g minus delivered)-3.6 pp-10.7 pp5th most demanding of 10
ROIC minus cost of capital+6.0 pp-3.3 pp6th highest of 19
EV / EBITDA13.2×18.6×3rd cheapest of 7
Net debt / EBITDA-1.4×-1.0×4th least indebted of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Tactile Systems Technology TCMDUnited States$592M+6%+14%9%21.1×8.4%+12.0%
Hangzhou AGS MedTech 688581.SSChina$590M-22%-18%33%18.9×0.4%+27.8%
vVARDIS VVVVUnited States$594Mn/a+148%-72%n/an/an/a
Ningbo David Medical Device 300314.SZChina$589M+25%+19%11%12.0×n/an/a
Sahajanand Medical Technologies SMT.NSIndia$595Mn/an/an/an/an/an/a
Orchestra BioMed OBIOUnited States$587M+87%+1,007%-195%n/an/an/a
Sight Sciences SGHTUnited States$599M+122%+16%-30%n/an/an/a
Medistim MEDI.OLNorway$599M+32%+19%29%31.8×-1.2%+14.5%
Nanosonics NAN.AXAustralia$599M-4%+3%7%98.6×35.3%+6.7%
Jiangsu Hanvo Safety Product 300952.SZChina$575M-38%+6%8%39.7×n/an/a
Xvivo Perfusion XVIVO.STSweden$611M-32%+18%12%53.1×35.9%+35.2%
Pacific Biosciences of California PACBUnited States$573M+54%+4%-98%n/an/an/a
Beijing Chunlizhengda Medical Instruments 688236.SSChina$618M-27%-13%31%17.4×-8.5%+2.2%
Wuhan Huakang Century Clean Technology 301235.SZChina$563M-57%+28%7%33.7×n/an/a
Cowealth Medical China 603122.SSChina$562M-34%-18%-5%n/an/an/a
SunMax Biotechnology 4728.TWOTaiwan$630M0%+19%51%n/a-2.6%+18.8%
Contec Medical Systems 300869.SZChina$547M-26%-2%-16%n/a15.0%-19.8%
AK Medical 1789.HKHong Kong$642M-23%+16%26%10.5×-11.5%+6.7%
Zhejiang Gongdong Medical Technology 605369.SSChina$542M-21%+6%9%23.5×10.2%+6.5%
QuidelOrtho QDELUnited States$657M-20%-5%-2%10.7×n/an/a
Jin Medical International ZJYLUnited States$532M+47%-14%2%n/an/an/a

Questions

Which companies are Tactile Systems Technology's closest peers?
The cockpit's peer set: Hangzhou AGS MedTech (688581.SS), vVARDIS (VVVV), Ningbo David Medical Device (300314.SZ), Sahajanand Medical Technologies (SMT.NS), Orchestra BioMed (OBIO), Sight Sciences (SGHT), Medistim (MEDI.OL), Nanosonics (NAN.AX).
Is Tactile Systems Technology expensive compared with its peers?
On forward p/e it trades at 21.1× against a peer median of 23.5×, 6th cheapest of 12 in its peer set. For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is -4 pp: the price already allows for a slowdown.
How has Tactile Systems Technology stock performed?
Over six months to 18 Nov 2026 the shares returned +6.4% against -20.3% for the median peer; over one year +12.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.